391 related articles for article (PubMed ID: 34160433)
21. Seroprevalence of SARS-CoV-2-specific anti-spike IgM, IgG, and anti-nucleocapsid IgG antibodies during the second wave of the pandemic: A population-based cross-sectional survey across Kashmir, India.
Lone KS; Khan SMS; Qurieshi MA; Majid S; Pandit MI; Haq I; Ahmad J; Bhat AA; Bashir K; Bilquees S; Fazili AB; Hassan M; Jan Y; Kaul RR; Khan ZA; Mushtaq B; Nazir F; Qureshi UA; Raja MW; Rasool M; Asma A; Bhat AA; Chowdri IN; Ismail S; Jeelani A; Kawoosa MF; Khan MA; Khan MS; Kousar R; Lone AA; Nabi S; Qazi TB; Rather RH; Sabah I; Sumji IA
Front Public Health; 2022; 10():967447. PubMed ID: 36276377
[TBL] [Abstract][Full Text] [Related]
22. Quantitative SARS-CoV-2 Antibody Screening of Healthcare Workers in the Southern Part of Kyoto City During the COVID-19 Pre-pandemic Period.
Fujita K; Kada S; Kanai O; Hata H; Odagaki T; Satoh-Asahara N; Tagami T; Yasoda A
Front Public Health; 2020; 8():595348. PubMed ID: 33365297
[No Abstract] [Full Text] [Related]
23. SARS-CoV-2 seroprevalence in healthcare workers in a high-volume ophthalmology centre in Guatemala.
Davila-Siliezar P; Wer A; Barnoya J
Ann Med; 2021 Dec; 53(1):1956-1959. PubMed ID: 34727801
[TBL] [Abstract][Full Text] [Related]
24. Prevalence, Persistence, and Factors Associated with SARS-CoV-2 IgG Seropositivity in a Large Cohort of Healthcare Workers in a Tertiary Care University Hospital in Northern Italy.
Scozzari G; Costa C; Migliore E; Coggiola M; Ciccone G; Savio L; Scarmozzino A; Pira E; Cassoni P; Galassi C; Cavallo R; The Collaborative Group
Viruses; 2021 Jun; 13(6):. PubMed ID: 34205134
[TBL] [Abstract][Full Text] [Related]
25. Seroprevalence of SARS-CoV-2-specific antibodies in cancer outpatients in Madrid (Spain): A single center, prospective, cohort study and a review of available data.
Cabezón-Gutiérrez L; Custodio-Cabello S; Palka-Kotlowska M; Oliveros-Acebes E; García-Navarro MJ; Khosravi-Shahi P
Cancer Treat Rev; 2020 Nov; 90():102102. PubMed ID: 32947121
[TBL] [Abstract][Full Text] [Related]
26. Radioligand Assay-Based Detection of Antibodies against SARS-CoV-2 in Hospital Workers Treating Patients with Severe COVID-19 in Japan.
Matsunaga H; Makino A; Kato Y; Murakami T; Yamaguchi Y; Kumanogoh A; Oba Y; Fujimi S; Honda T; Tomonaga K
Viruses; 2021 Feb; 13(2):. PubMed ID: 33672213
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of Health Care and Hospital Worker SARS-CoV-2 IgG Antibody in a Pediatric Hospital.
Tokareva Y; Englund JA; Dickerson JA; Brown JC; Zerr DM; Walter E; Tsogoo A; Cappetto K; Valdez Gonzalez J; Strelitz B; Klein EJ
Hosp Pediatr; 2021 Mar; 11(3):e48-e53. PubMed ID: 33361400
[TBL] [Abstract][Full Text] [Related]
28. Seroprevalence of SARS-CoV-2 antibodies among hospital workers in a German tertiary care center: A sequential follow-up study.
Brehm TT; Schwinge D; Lampalzer S; Schlicker V; Küchen J; Thompson M; Ullrich F; Huber S; Schmiedel S; Addo MM; Lütgehetmann M; Knobloch JK; Schulze Zur Wiesch J; Lohse AW
Int J Hyg Environ Health; 2021 Mar; 232():113671. PubMed ID: 33338782
[TBL] [Abstract][Full Text] [Related]
29. Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers & implications of infection control practice in India.
Gupta R; Dwivedi T; Gajendra S; Sahoo B; Gupta SK; Vikas H; Singh AR; Mohan A; Bhatnagar S; Singh S; Wundavalli L; Guleria R
Indian J Med Res; 2021 Jan & Feb; 153(1 & 2):207-213. PubMed ID: 33642348
[TBL] [Abstract][Full Text] [Related]
30. Demographic and occupational determinants of anti-SARS-CoV-2 IgG seropositivity in hospital staff.
Martin CA; Patel P; Goss C; Jenkins DR; Price A; Barton L; Gupta P; Zaccardi F; Jerina H; Duraisingham S; Brunskill NJ; Khunti K; Pareek M
J Public Health (Oxf); 2022 Jun; 44(2):234-245. PubMed ID: 33200200
[TBL] [Abstract][Full Text] [Related]
31. High SARS-CoV-2 Prevalence among Healthcare Workers in Cochabamba, Bolivia.
Saba Villarroel PM; Castro Soto MDR; Undurraga V; Sanz H; Jaldín AM; Ninove L; Nurtop E; Pezzi L; Mohamed Ali S; Amroun A; Seston M; de Lamballerie X
Viruses; 2022 Jan; 14(2):. PubMed ID: 35215826
[TBL] [Abstract][Full Text] [Related]
32. SARS-CoV-2 IgG seroprevalence among medical staff in a general hospital that treated patients with COVID-19 in Japan: retrospective evaluation of nosocomial infection control.
Hibino M; Iwabuchi S; Munakata H
J Hosp Infect; 2021 Jan; 107():103-104. PubMed ID: 33039454
[No Abstract] [Full Text] [Related]
33. Seroprevalence of Unidentified SARS-CoV-2 Infection in Hong Kong During 3 Pandemic Waves.
Boon SS; Wong MCS; Ng RWY; Leung DTM; Chen Z; Lai CKC; Ho WCS; Huang J; Wong BKC; Fung KSC; Chan PKS
JAMA Netw Open; 2021 Nov; 4(11):e2132923. PubMed ID: 34779848
[TBL] [Abstract][Full Text] [Related]
34. Antibody response using six different serological assays in a completely PCR-tested community after a coronavirus disease 2019 outbreak-the CoNAN study.
Weis S; Scherag A; Baier M; Kiehntopf M; Kamradt T; Kolanos S; Ankert J; Glöckner S; Makarewicz O; Hagel S; Bahrs C; Kimmig A; Proquitté H; Guerra J; Rimek D; Löffler B; Pletz MW;
Clin Microbiol Infect; 2021 Mar; 27(3):470.e1-470.e9. PubMed ID: 33221432
[TBL] [Abstract][Full Text] [Related]
35. Prevalence and associated characteristics of anti-SARS-CoV-2 antibodies in Mexico 5 months after pandemic arrival.
Díaz-Salazar C; Sánchez-García A; Rodríguez-Gutiérrez R; Camacho-Ortiz A; Saldívar-Rodríguez D; González-González JG
BMC Infect Dis; 2021 Aug; 21(1):835. PubMed ID: 34412620
[TBL] [Abstract][Full Text] [Related]
36. Seroprevalence of SARS-CoV-2 Binding and Neutralizing Antibodies in Healthcare Workers during the Epidemic Peak in Referral Hospitals and Quarantine Sites: Saudi Arabia.
Alhabbab RY; Alsaieedi A; Algaissi A; Almahboub S; Al-Raddadi RM; Shabouni OI; Alhabbab R; Alfaraj AA; Alamri SS; Aljehani ND; Abdulal RH; Alfaleh MA; Abujamel TS; Alkayyal AA; Mahmoud AB; Abuzenadah AM; Hashem AM
Viruses; 2021 Jul; 13(7):. PubMed ID: 34372618
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of SARS-CoV-2 Infection in Children and Their Parents in Southwest Germany.
Tönshoff B; Müller B; Elling R; Renk H; Meissner P; Hengel H; Garbade SF; Kieser M; Jeltsch K; Grulich-Henn J; Euler J; Stich M; Chobanyan-Jürgens K; Zernickel M; Janda A; Wölfle L; Stamminger T; Iftner T; Ganzenmueller T; Schmitt C; Görne T; Laketa V; Olberg S; Plaszczyca A; Cortese M; Bartenschlager R; Pape C; Remme R; Huzly D; Panning M; Weigang S; Giese S; Ciminski K; Ankerhold J; Kochs G; Schwemmle M; Handgretinger R; Niemeyer CM; Engel C; Kern WV; Hoffmann GF; Franz AR; Henneke P; Debatin KM; Kräusslich HG
JAMA Pediatr; 2021 Jun; 175(6):586-593. PubMed ID: 33480966
[TBL] [Abstract][Full Text] [Related]
38. High SARS-CoV-2 Seroprevalence in Rural Peru, 2021: a Cross-Sectional Population-Based Study.
Moreira-Soto A; Pachamora Diaz JM; González-Auza L; Merino Merino XJ; Schwalb A; Drosten C; Gotuzzo E; Talledo M; Arévalo Ramirez H; Peralta Delgado R; Bocanegra Vargas S; Drexler JF
mSphere; 2021 Dec; 6(6):e0068521. PubMed ID: 34817236
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of antibodies to SARS-CoV-2 in Irish hospital healthcare workers.
Allen N; Riain UN; Conlon N; Ferenczi A; Carrion Martin AI; Domegan L; Walsh C; Doherty L; O'Farrelly C; Higgins E; Kerr C; McGrath J; ; Fleming C; Bergin C
Epidemiol Infect; 2021 Apr; 149():e157. PubMed ID: 33902786
[TBL] [Abstract][Full Text] [Related]
40. Population-based seroprevalence surveys of anti-SARS-CoV-2 antibody: An up-to-date review.
Lai CC; Wang JH; Hsueh PR
Int J Infect Dis; 2020 Dec; 101():314-322. PubMed ID: 33045429
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
